Eric Ferrandis

952 total citations
27 papers, 761 citations indexed

About

Eric Ferrandis is a scholar working on Molecular Biology, Organic Chemistry and Neurology. According to data from OpenAlex, Eric Ferrandis has authored 27 papers receiving a total of 761 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Organic Chemistry and 7 papers in Neurology. Recurrent topics in Eric Ferrandis's work include Neuroblastoma Research and Treatments (6 papers), Synthesis and Biological Evaluation (6 papers) and Estrogen and related hormone effects (5 papers). Eric Ferrandis is often cited by papers focused on Neuroblastoma Research and Treatments (6 papers), Synthesis and Biological Evaluation (6 papers) and Estrogen and related hormone effects (5 papers). Eric Ferrandis collaborates with scholars based in France, United Kingdom and United States. Eric Ferrandis's co-authors include Barry V. L. Potter, Mathew P. Leese, Fabrice Jourdan, Atul Purohit, Wolfgang Döhle, Michael Reed, Simon P. Newman, Ernest Hamel, Philip G. Kasprzyk and G Riou and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and Analytical Biochemistry.

In The Last Decade

Eric Ferrandis

26 papers receiving 755 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric Ferrandis France 16 412 320 140 137 97 27 761
Thomas Buhl Switzerland 18 314 0.8× 294 0.9× 92 0.7× 179 1.3× 9 0.1× 25 879
Ching-Shih Chen United States 11 468 1.1× 217 0.7× 237 1.7× 180 1.3× 36 0.4× 12 1.1k
Carla M. Suto United States 16 926 2.2× 176 0.6× 283 2.0× 163 1.2× 26 0.3× 21 1.2k
Esther Marco Spain 15 342 0.8× 225 0.7× 22 0.2× 117 0.9× 20 0.2× 28 789
T. MIYASAKA Japan 13 547 1.3× 215 0.7× 44 0.3× 189 1.4× 12 0.1× 37 861
Zahra Parandoosh United States 13 479 1.2× 165 0.5× 79 0.6× 97 0.7× 15 0.2× 31 692
Long G. Wang United States 10 465 1.1× 113 0.4× 66 0.5× 244 1.8× 8 0.1× 11 761
Puranik Purushottamachar United States 18 669 1.6× 165 0.5× 181 1.3× 145 1.1× 8 0.1× 45 1.0k
Lubna H. Tahtamouni Jordan 14 244 0.6× 177 0.6× 30 0.2× 97 0.7× 9 0.1× 64 714
Bharat Lagu United States 18 343 0.8× 390 1.2× 20 0.1× 87 0.6× 23 0.2× 36 740

Countries citing papers authored by Eric Ferrandis

Since Specialization
Citations

This map shows the geographic impact of Eric Ferrandis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Ferrandis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Ferrandis more than expected).

Fields of papers citing papers by Eric Ferrandis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Ferrandis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Ferrandis. The network helps show where Eric Ferrandis may publish in the future.

Co-authorship network of co-authors of Eric Ferrandis

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Ferrandis. A scholar is included among the top collaborators of Eric Ferrandis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Ferrandis. Eric Ferrandis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Döhle, Wolfgang, Mathew P. Leese, Fabrice Jourdan, et al.. (2014). Synthesis, Antitubulin, and Antiproliferative SAR of C3/C1‐Substituted Tetrahydroisoquinolines. ChemMedChem. 9(2). 350–370. 15 indexed citations
2.
Leese, Mathew P., Fabrice Jourdan, Wolfgang Döhle, et al.. (2014). Synthesis, Anti‐tubulin and Antiproliferative SAR of Steroidomimetic Dihydroisoquinolinones. ChemMedChem. 9(4). 798–812. 16 indexed citations
3.
Viossat, Isabelle, et al.. (2014). Novel azoles as potent and selective cannabinoid CB2 receptor agonists. Bioorganic & Medicinal Chemistry Letters. 25(1). 88–91. 4 indexed citations
4.
Döhle, Wolfgang, Mathew P. Leese, Fabrice Jourdan, et al.. (2014). Optimisation of Tetrahydroisoquinoline‐Based Chimeric Microtubule Disruptors. ChemMedChem. 9(8). 1783–1793. 12 indexed citations
5.
Leese, Mathew P., Fabrice Jourdan, Wolfgang Döhle, et al.. (2013). Tetrahydroisoquinolinone‐Based Steroidomimetic and Chimeric Microtubule Disruptors. ChemMedChem. 9(1). 85–108. 15 indexed citations
6.
Spinnewyn, B., Gisèle Mautino, Jean‐Grégoire Marin, et al.. (2010). BN82451 attenuates l-dopa-induced dyskinesia in 6-OHDA-lesioned rat model of Parkinson’s disease. Neuropharmacology. 60(4). 692–700. 12 indexed citations
7.
Leese, Mathew P., Fabrice Jourdan, Gyles E. Cozier, et al.. (2010). Chimeric microtubule disruptors. Chemical Communications. 46(17). 2907–2907. 25 indexed citations
8.
Jourdan, Fabrice, Mathew P. Leese, Wolfgang Döhle, et al.. (2010). Synthesis, Antitubulin, and Antiproliferative SAR of Analogues of 2-Methoxyestradiol-3,17-O,O-bis-sulfamate. Journal of Medicinal Chemistry. 53(7). 2942–2951. 37 indexed citations
9.
Ferrandis, Eric, Caroline Touvay, Ian Wilkinson, et al.. (2010). Immunogenicity, toxicology, pharmacokinetics and pharmacodynamics of growth hormone ligand–receptor fusions. Clinical Science. 119(11). 483–491. 9 indexed citations
10.
Ayoub, Mohammed Akli, Marjorie Damian, Christian Gespach, et al.. (2009). Inhibition of Heterotrimeric G Protein Signaling by a Small Molecule Acting on Gα Subunit. Journal of Biological Chemistry. 284(42). 29136–29145. 61 indexed citations
11.
Allan, G.M., Nigel Vicker, Harshani R. Lawrence, et al.. (2008). Novel inhibitors of 17β-hydroxysteroid dehydrogenase type 1: Templates for design. Bioorganic & Medicinal Chemistry. 16(8). 4438–4456. 38 indexed citations
12.
Jourdan, Fabrice, Christian Bubert, Mathew P. Leese, et al.. (2008). Effects of C-17 heterocyclic substituents on the anticancer activity of 2-ethylestra-1,3,5(10)-triene-3-O-sulfamates: synthesis, in vitro evaluation and computational modelling. Organic & Biomolecular Chemistry. 6(22). 4108–4108. 30 indexed citations
13.
Leese, Mathew P., Fabrice Jourdan, Keira Gaukroger, et al.. (2008). Structure–Activity Relationships of C-17 Cyano-Substituted Estratrienes as Anticancer Agents. Journal of Medicinal Chemistry. 51(5). 1295–1308. 49 indexed citations
14.
Wilkinson, Ian, Eric Ferrandis, Peter J. Artymiuk, et al.. (2007). A ligand-receptor fusion of growth hormone forms a dimer and is a potent long-acting agonist. Nature Medicine. 13(9). 1108–1113. 26 indexed citations
15.
Bubert, Christian, Mathew P. Leese, Mary F. Mahon, et al.. (2007). 3,17-Disubstituted 2-Alkylestra-1,3,5(10)-trien-3-ol Derivatives:  Synthesis, In Vitro and In Vivo Anticancer Activity. Journal of Medicinal Chemistry. 50(18). 4431–4443. 53 indexed citations
16.
Blanc, Étienne, David Goldschneider, Eric Ferrandis, et al.. (2003). MYCN Enhances P-gp/MDR1 Gene Expression in the Human Metastatic Neuroblastoma IGR-N-91 Model. American Journal Of Pathology. 163(1). 321–331. 34 indexed citations
17.
Paterlini-Bréchot, Patrizia, Eric Ferrandis, Arnaud Méjean, et al.. (1997). Evaluation of Cell Proliferation through a Polymerase Chain Reaction-Based Cyclin A Test. Analytical Biochemistry. 253(1). 140–142. 1 indexed citations
18.
Müller, Catherine, F Goubin, Eric Ferrandis, et al.. (1995). Evidence for transcriptional control of human mdr1 gene expression by verapamil in multidrug-resistant leukemic cells.. Molecular Pharmacology. 47(1). 51–56. 63 indexed citations
19.
Ferrandis, Eric, et al.. (1994). Coactivation of the MDR1 and MYCN genes in human neuroblastoma cells during the metastatic process in the nude mouse.. PubMed. 54(8). 2256–61. 56 indexed citations
20.
Ferrandis, Eric & Jean Bénard. (1993). Activation of the human mdr1 gene promoter in differentiated neuroblasts. International Journal of Cancer. 54(6). 987–991. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas Buhl Breakdown of academic impact, for papers by Ching-Shih Chen Breakdown of academic impact, for papers by Carla M. Suto Breakdown of academic impact, for papers by Esther Marco Breakdown of academic impact, for papers by T. MIYASAKA Breakdown of academic impact, for papers by Zahra Parandoosh Breakdown of academic impact, for papers by Long G. Wang Breakdown of academic impact, for papers by Puranik Purushottamachar Breakdown of academic impact, for papers by Lubna H. Tahtamouni Breakdown of academic impact, for papers by Bharat Lagu
Rankless by CCL
2026